• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒:先天免疫、炎症小体激活、炎症细胞死亡和细胞因子。

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

机构信息

Department of Immunology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA; Department of Acute and Tertiary Care, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.

出版信息

Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.

DOI:10.1016/j.it.2020.10.005
PMID:33153908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7561287/
Abstract

The innate immune system acts as the first line of defense against pathogens, including coronaviruses (CoVs). Severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV are epidemic zoonotic CoVs that emerged at the beginning of the 21st century. The recently emerged virus SARS-CoV-2 is a novel strain of CoV that has caused the coronavirus 2019 (COVID-19) pandemic. Scientific advancements made by studying the SARS-CoV and MERS-CoV outbreaks have provided a foundation for understanding pathogenesis and innate immunity against SARS-CoV-2. In this review, we focus on our present understanding of innate immune responses, inflammasome activation, inflammatory cell death pathways, and cytokine secretion during SARS-CoV, MERS-CoV, and SARS-CoV-2 infection. We also discuss how the pathogenesis of these viruses influences these biological processes.

摘要

先天免疫系统是抵御病原体的第一道防线,包括冠状病毒(CoV)。严重急性呼吸综合征(SARS)-CoV 和中东呼吸综合征(MERS)-CoV 是 21 世纪初出现的流行的人畜共患 CoV。最近出现的病毒 SARS-CoV-2 是一种新型冠状病毒株,引起了冠状病毒 2019(COVID-19)大流行。通过研究 SARS-CoV 和 MERS-CoV 爆发所取得的科学进展为了解 SARS-CoV-2 的发病机制和先天免疫提供了基础。在这篇综述中,我们重点介绍了我们目前对 SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染期间先天免疫反应、炎性小体激活、炎症细胞死亡途径和细胞因子分泌的理解。我们还讨论了这些病毒的发病机制如何影响这些生物学过程。

相似文献

1
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.冠状病毒:先天免疫、炎症小体激活、炎症细胞死亡和细胞因子。
Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.
2
Inflammasomes and SARS-CoV-2 Infection.炎症小体与 SARS-CoV-2 感染
Viruses. 2021 Dec 14;13(12):2513. doi: 10.3390/v13122513.
3
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.严重急性呼吸综合征冠状病毒 2 型和其他冠状病毒对固有免疫激活的控制。
J Interferon Cytokine Res. 2021 Jun;41(6):205-219. doi: 10.1089/jir.2021.0060.
4
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.冠状病毒感染和新冠肺炎期间天然免疫在保护及发病机制中的作用
Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.
5
Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.炎症小体在驱动人类 COVID-19 严重程度和蝙蝠免疫耐受中的调控作用。
J Leukoc Biol. 2022 Feb;111(2):497-508. doi: 10.1002/JLB.4COVHR0221-093RR. Epub 2021 May 31.
6
Innate immunity: the first line of defense against SARS-CoV-2.先天免疫:抵御 SARS-CoV-2 的第一道防线。
Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1.
7
Differences and similarities between innate immune evasion strategies of human coronaviruses.人类冠状病毒固有免疫逃避策略的异同。
Curr Opin Microbiol. 2024 Jun;79:102466. doi: 10.1016/j.mib.2024.102466. Epub 2024 Mar 30.
8
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.SARS-CoV-2 引发的固有免疫反应的逃逸和过度激活:一枚硬币的两面。
Viruses. 2022 Mar 4;14(3):530. doi: 10.3390/v14030530.
9
A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 的发病机制和宿主固有免疫逃避策略的比较综述。
Arch Microbiol. 2021 Jul;203(5):1943-1951. doi: 10.1007/s00203-021-02265-y. Epub 2021 Mar 7.
10
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.COVID-19 中的固有免疫、细胞因子风暴和炎症细胞死亡。
J Transl Med. 2022 Nov 22;20(1):542. doi: 10.1186/s12967-022-03767-z.

引用本文的文献

1
Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.新型冠状病毒感染中的固有免疫、治疗靶点及单克隆抗体
PeerJ. 2025 Jun 20;13:e19462. doi: 10.7717/peerj.19462. eCollection 2025.
2
Pattern recognition receptors and inflammasome: Now and beyond.模式识别受体与炎性小体:现状与展望
Mol Cells. 2025 Aug;48(8):100239. doi: 10.1016/j.mocell.2025.100239. Epub 2025 Jun 15.
3
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.白细胞介素-1β独立于炎性小体和细胞焦亡信号传导驱动新冠病毒诱导的疾病。

本文引用的文献

1
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.秋水仙碱:一种对抗新冠病毒的潜在治疗工具。5例患者的经验。
Reumatol Clin. 2021 Aug-Sep;17(7):371-375. doi: 10.1016/j.reuma.2020.05.001. Epub 2020 May 16.
2
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.重症 COVID-19 患者中白细胞介素-6 的抑制与继发性感染增加有关。
Front Med (Lausanne). 2020 Oct 28;7:583897. doi: 10.3389/fmed.2020.583897. eCollection 2020.
3
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Cell Death Differ. 2025 Feb 28. doi: 10.1038/s41418-025-01459-x.
4
The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections.炎症在病毒性呼吸道感染发病机制中的作用
Microorganisms. 2024 Dec 7;12(12):2526. doi: 10.3390/microorganisms12122526.
5
The Impact of Deep Local Lung Hyperthermia on COVID-19 Cancer Patients.深部局部肺部热疗对新冠癌症患者的影响
Adv Biomed Res. 2024 Oct 28;13:92. doi: 10.4103/abr.abr_75_23. eCollection 2024.
6
Mucosal immunity in COVID-19: a comprehensive review.COVID-19 中的黏膜免疫:全面综述。
Front Immunol. 2024 Aug 14;15:1433452. doi: 10.3389/fimmu.2024.1433452. eCollection 2024.
7
The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections.Nrf2 通路在病毒呼吸道感染导致的气道组织损伤中的作用。
Int J Mol Sci. 2024 Jun 27;25(13):7042. doi: 10.3390/ijms25137042.
8
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.冠状病毒感染和新冠肺炎期间天然免疫在保护及发病机制中的作用
Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.
9
Harnessing the power of IFN for therapeutic approaches to COVID-19.利用 IFN 的力量寻求 COVID-19 的治疗方法。
J Virol. 2024 May 14;98(5):e0120423. doi: 10.1128/jvi.01204-23. Epub 2024 Apr 23.
10
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication.感染时肺部的炎症微环境决定了对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制的固有控制。
bioRxiv. 2024 Mar 27:2024.03.27.586885. doi: 10.1101/2024.03.27.586885.
COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
4
Sex differences in immune responses that underlie COVID-19 disease outcomes.COVID-19 疾病结局相关的免疫反应中的性别差异。
Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26.
5
Anakinra for severe forms of COVID-19: a cohort study.阿那白滞素用于重症新型冠状病毒肺炎:一项队列研究。
Lancet Rheumatol. 2020 Jul;2(7):e393-e400. doi: 10.1016/S2665-9913(20)30164-8. Epub 2020 May 29.
6
Anakinra in COVID-19: important considerations for clinical trials.阿那白滞素用于新型冠状病毒肺炎:临床试验的重要考量因素
Lancet Rheumatol. 2020 Jul;2(7):e379-e381. doi: 10.1016/S2665-9913(20)30160-0. Epub 2020 May 21.
7
PANoptosis in microbial infection.微生物感染中的全细胞凋亡。
Curr Opin Microbiol. 2021 Feb;59:42-49. doi: 10.1016/j.mib.2020.07.012. Epub 2020 Aug 20.
8
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.人类对轻度与重度 COVID-19 感染免疫的系统生物学评估。
Science. 2020 Sep 4;369(6508):1210-1220. doi: 10.1126/science.abc6261. Epub 2020 Aug 11.
9
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.SARS-CoV-2 感染人呼吸道上皮细胞的形态发生和细胞病变效应。
Nat Commun. 2020 Aug 6;11(1):3910. doi: 10.1038/s41467-020-17796-z.
10
Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.冠状病毒感染过程中,NLRP3 炎性小体激活/焦亡受损会通过 caspase-8/RIPK3 导致炎症细胞大量死亡。
J Biol Chem. 2020 Oct 9;295(41):14040-14052. doi: 10.1074/jbc.RA120.015036. Epub 2020 Aug 6.